Jefferies Group LLC Eli Lilly & CO Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Jefferies Group LLC holds 67,267 shares of LLY stock, worth $53.8 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

67,267

Previous 89,654 24.97%

Holding current value

$53.8 Million

Previous $29.1 Million 25.18%

% of portfolio

0.21%

Previous 0.29%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	SELL	$296.48 - $337.87 $6.64 Million - $7.56 Million	-22,387 Reduced 24.97%	67,267 $21.8 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $6.55 Million - $7.47 Million	-22,095 Reduced 23.94%	70,199 $21.8 Million
Q2 2022 Sep 21, 2023	SELL	$278.73 - $327.27 $2.16 Million - $2.54 Million	-7,747 Reduced 7.95%	89,654 $29.1 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $1.8 Million - $2.11 Million	-6,443 Reduced 6.53%	92,294 $29.1 Million
Q1 2022 Sep 21, 2023	BUY	$234.69 - $291.66 $17.1 Million - $21.3 Million	73,045 Added 299.91%	97,401 $27.9 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $17.5 Million - $21.7 Million	74,381 Added 305.39%	98,737 $27.9 Million
Q4 2021 Sep 21, 2023	BUY	$224.85 - $279.04 $2.88 Million - $3.57 Million	12,806 Added 110.87%	24,356 $6.73 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $2.88 Million - $3.57 Million	12,806 Added 110.87%	24,356 $6.73 Million
Q3 2021 Sep 21, 2023	BUY	$221.6 - $272.71 $2.16 Million - $2.65 Million	9,732 Added 535.31%	11,550 $2.67 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $2.16 Million - $2.65 Million	9,732 Added 535.31%	11,550 $2.67 Million
Q2 2021 Sep 21, 2023	SELL	$180.55 - $233.54 $1.83 Million - $2.37 Million	-10,127 Reduced 84.78%	1,818 $417,000
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $1.83 Million - $2.37 Million	-10,127 Reduced 84.78%	1,818 $417,000
Q1 2021 Sep 21, 2023	SELL	$164.32 - $212.72 $1.46 Million - $1.89 Million	-8,866 Reduced 42.6%	11,945 $2.23 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $1.46 Million - $1.89 Million	-8,866 Reduced 42.6%	11,945 $2.23 Million
Q4 2020 Sep 21, 2023	SELL	$130.46 - $172.63 $6.44 Million - $8.53 Million	-49,388 Reduced 70.35%	20,811 $3.51 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $5.5 Million - $7.28 Million	-42,174 Reduced 66.96%	20,811 $3.51 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $7.61 Million - $8.8 Million	52,043 Added 475.63%	62,985 $9.32 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $2.74 Million - $3.29 Million	-20,064 Reduced 64.71%	10,942 $1.8 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $2.31 Million - $2.85 Million	19,363 Added 166.31%	31,006 $4.3 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $1.45 Million - $1.8 Million	-13,601 Reduced 53.88%	11,643 $1.53 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $5.4 Million - $5.87 Million	-50,544 Reduced 66.69%	25,244 $2.82 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $7.37 Million - $8.6 Million	66,490 Added 715.1%	75,788 $8.4 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $8.78 Million - $10.3 Million	-78,834 Reduced 89.45%	9,298 $1.21 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $1.22 Million - $1.37 Million	-11,528 Reduced 11.57%	88,132 $10.2 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $6.93 Million - $8.66 Million	80,692 Added 425.41%	99,660 $10.7 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $852,760 - $978,703	11,265 Added 146.24%	18,968 $1.62 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $18.9 Million - $22.3 Million	-254,155 Reduced 97.06%	7,703 $596,000
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $16.9 Million - $18.1 Million	205,712 Added 366.39%	261,858 $22.1 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $4.33 Million - $4.8 Million	56,146	56,146 $4.8 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account

Jefferies Group LLC Eli Lilly & CO Transaction History